{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:27:05Z","timestamp":1790486825954,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.xphs.2021.08.013","type":"journal-article","created":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T10:30:45Z","timestamp":1628937045000},"page":"3953-3962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse Model"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1769-389X","authenticated-orcid":false,"given":"Elena","family":"Puris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Auriola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5856-1474","authenticated-orcid":false,"given":"Paula","family":"Korhonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8848-0453","authenticated-orcid":false,"given":"Sanna","family":"Loppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja M.","family":"Kanninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Koistinaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-7489","authenticated-orcid":false,"given":"Mikko","family":"Gynther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.xphs.2021.08.013_bib0001","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer\u2019s disease facts and figures","volume":"12","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer's disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.xphs.2021.08.013_bib0003","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.xphs.2021.08.013_bib0004","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"issue":"8","key":"10.1016\/j.xphs.2021.08.013_bib0005","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/acschemneuro.9b00333","article-title":"Understanding the role of systemic inflammation in Alzheimer's disease","volume":"10","author":"Walker","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"2-3","key":"10.1016\/j.xphs.2021.08.013_bib0006","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000357568","article-title":"We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective","volume":"13","author":"Windisch","year":"2014","journal-title":"Neurodegener Dis"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.013_bib0007","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/hmg\/ddh019","article-title":"Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase","volume":"13","author":"Jankowsky","year":"2004","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.xphs.2021.08.013_bib0008","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.neurobiolaging.2008.11.006","article-title":"Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice","volume":"31","author":"Garcia-Alloza","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2009.12.023","article-title":"Functional cholinergic damage develops with amyloid accumulation in young adult APPswe\/PS1dE9 transgenic mice","volume":"38","author":"Machova","year":"2010","journal-title":"Neurobiol Dis"},{"issue":"40","key":"10.1016\/j.xphs.2021.08.013_bib0010","doi-asserted-by":"crossref","first-page":"12636","DOI":"10.1523\/JNEUROSCI.1948-09.2009","article-title":"A reporter of local dendritic translocation shows plaque- related loss of neural system function in APP-transgenic mice","volume":"29","author":"Meyer-Luehmann","year":"2009","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.013_bib0011","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12264-011-1015-7","article-title":"Biochemical and behavioral characterization of the double transgenic mouse model (APPswe\/PS1dE9) of Alzheimer's disease","volume":"27","author":"Xiong","year":"2011","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.xphs.2021.08.013_bib0012","doi-asserted-by":"crossref","unstructured":"Puris E, Kou\u0159il S, Najdekr L, et\u00a0al. Gynther M in press. Metabolomic and lipidomic changes triggered by lipopolysaccharide-induced systemic inflammation in transgenic APdE9 mice. Scientific Reports. 2021;11(1):13076.","DOI":"10.1038\/s41598-021-92602-4"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.013_bib0014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1570159X14666151204122017","article-title":"LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals","volume":"14","author":"Catorce","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.xphs.2021.08.013_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The role of NMDA receptors in Alzheimer's disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front Neurosci"},{"issue":"8","key":"10.1016\/j.xphs.2021.08.013_bib0017","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J Gen Physiol"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.013_bib0018","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.013_bib0019","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3233\/JAD-141764","article-title":"Differential alterations of neocortical GluN receptor subunits in patients with mixed subcortical ischemic vascular dementia and Alzheimer's disease","volume":"44","author":"Mohamed","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.xphs.2021.08.013_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147135","article-title":"Endocannabinoid system alterations in Alzheimer's disease: A systematic review of human studies","volume":"1749","author":"Berry","year":"2020","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1096\/fj.201800355RRRR","article-title":"Integrated communications between cyclooxygenase-2 and Alzheimer's disease","volume":"33","author":"Guan","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.013_bib0022","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bcp.2013.12.014","article-title":"Therapeutic implications of the prostaglandin pathway in Alzheimer's disease","volume":"88","author":"Cudaback","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xphs.2021.08.013_bib0023","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2015.12.003","article-title":"Role of cox-2 mediated neuroinflammation on the neurodegeneration and cognitive impairments in colchicine induced rat model of Alzheimer's Disease","volume":"291","author":"Sil","year":"2016","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.013_bib0024","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12264-016-0055-4","article-title":"Inflammatory cytokines and Alzheimer's disease: a review from the perspective of genetic polymorphisms","volume":"32","author":"Su","year":"2016","journal-title":"Neurosci Bull"},{"key":"10.1016\/j.xphs.2021.08.013_bib0025","doi-asserted-by":"crossref","first-page":"4050796","DOI":"10.1155\/2019\/4050796","article-title":"The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation","volume":"2019","author":"Bajwa","year":"2019","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.013_bib0026","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3233\/JAD-170639","article-title":"ABC transporters are key players in Alzheimer's disease","volume":"61","author":"Pereira","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.013_bib0027","doi-asserted-by":"crossref","first-page":"390","DOI":"10.14336\/AD.2019.0519","article-title":"Alteration in the function and expression of SLC and ABC transporters in the Neurovascular Unit in Alzheimer's disease and the clinical significance","volume":"11","author":"Jia","year":"2020","journal-title":"Aging Dis"},{"issue":"11","key":"10.1016\/j.xphs.2021.08.013_bib0028","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1248\/bpb.b20-00388","article-title":"Inflammation-induced attenuation of prostaglandin D2 elimination across rat blood-brain barrier: involvement of the downregulation of organic anion transporter 3 and multidrug resistance-associated protein 4","volume":"43","author":"Akanuma","year":"2020","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.013_bib0029","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11095-020-02826-8","article-title":"L-Type amino acid transporter 1 as a target for drug delivery","volume":"37","author":"Puris","year":"2020","journal-title":"Pharm Res"},{"issue":"10","key":"10.1016\/j.xphs.2021.08.013_bib0030","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1021\/jm8015409","article-title":"Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats","volume":"52","author":"Gynther","year":"2009","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.013_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s007020200028","article-title":"The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: an update","volume":"109","author":"Hoyer","year":"2002","journal-title":"J Neural Transm"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0032","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1567205010666131119235254","article-title":"Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease","volume":"11","author":"Lyros","year":"2014","journal-title":"Curr Alzheimer Res"},{"issue":"Suppl 3","key":"10.1016\/j.xphs.2021.08.013_bib0033","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JAD-2011-0066","article-title":"Amyloid-beta and glucose metabolism in Alzheimer's disease","volume":"26","author":"Furst","year":"2011","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.013_bib0034","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1021\/acs.molpharmaceut.8b01189","article-title":"Proteomic quantification of human blood-brain barrier SLC and ABC transporters in healthy individuals and dementia patients","volume":"16","author":"Al-Majdoub","year":"2019","journal-title":"Mol Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.013_bib0035","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cpt.2035","article-title":"Abundance of P-glycoprotein and other drug transporters at the human blood-brain barrier in Alzheimer's disease: a quantitative targeted proteomic study","volume":"109","author":"Storelli","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0036","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-10-21","volume":"10","author":"Uchida","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"10.1016\/j.xphs.2021.08.013_bib0037","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/acs.molpharmaceut.8b00500","article-title":"Altered expression of small intestinal drug transporters and hepatic metabolic enzymes in a mouse model of familial Alzheimer's disease","volume":"15","author":"Pan","year":"2018","journal-title":"Mol Pharm"},{"issue":"7","key":"10.1016\/j.xphs.2021.08.013_bib0038","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.xphs.2019.02.016","article-title":"Increased expression of renal drug transporters in a mouse model of familial Alzheimer's disease","volume":"108","author":"Pan","year":"2019","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.xphs.2021.08.013_bib0039","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1002\/jps.22612","article-title":"Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects","volume":"100","author":"Ohtsuki","year":"2011","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2021.08.013_bib0040","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1471-4159.2007.05147.x","article-title":"Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP\/PS1 transgenic and wild-type mice","volume":"105","author":"Minkeviciene","year":"2008","journal-title":"J Neurochem"},{"issue":"23","key":"10.1016\/j.xphs.2021.08.013_bib0041","doi-asserted-by":"crossref","first-page":"9885","DOI":"10.1021\/acs.jmedchem.7b01624","article-title":"Augmentation of anticancer drug efficacy in murine hepatocellular carcinoma cells by a peripherally acting competitive N-Methyl-d-aspartate (NMDA) receptor antagonist","volume":"60","author":"Gynther","year":"2017","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.xphs.2021.08.013_bib0042","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acs.molpharmaceut.9b00502","article-title":"Mechanistic study on the use of the l-Type amino acid transporter 1 for brain intracellular delivery of ketoprofen via prodrug: a novel approach supporting the development of prodrugs for intracellular targets","volume":"16","author":"Puris","year":"2019","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11095-018-2546-7","article-title":"Alzheimer's disease phenotype or inflammatory insult does not alter function of L-type amino acid Transporter 1 in mouse blood-brain barrier and primary astrocytes","volume":"36","author":"Gynther","year":"2018","journal-title":"Pharm Res"},{"issue":"6","key":"10.1016\/j.xphs.2021.08.013_bib0044","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC\/MS\/MS method combined with novel in-silico peptide selection criteria","volume":"25","author":"Kamiie","year":"2008","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.xphs.2021.08.013_bib0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.xphs.2021.08.013_bib0046","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3389\/fphys.2020.00398","article-title":"The isolated brain microvessel: a versatile experimental model of the blood-brain barrier","volume":"11","author":"Pardridge","year":"2020","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.xphs.2021.08.013_bib0047","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat Neurosci"},{"issue":"5","key":"10.1016\/j.xphs.2021.08.013_bib0048","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.celrep.2012.09.030","article-title":"Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease","volume":"2","author":"Chen","year":"2012","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.xphs.2021.08.013_bib0049","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0197-4580(01)00303-7","article-title":"Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease","volume":"22","author":"Yermakova","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.xphs.2021.08.013_bib0050","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s13311-019-00770-z","article-title":"Cyclooxygenase-2 induced the beta-amyloid protein deposition and neuronal apoptosis via upregulating the synthesis of Prostaglandin E2 and 15-Deoxy-Delta(12,14)-prostaglandin J2","volume":"16","author":"Guan","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.xphs.2021.08.013_bib0051","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jnen\/63.9.901","article-title":"Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases","volume":"63","author":"Minghetti","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6057","key":"10.1016\/j.xphs.2021.08.013_bib0052","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1209200","article-title":"Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation","volume":"334","author":"Nomura","year":"2011","journal-title":"Science"},{"issue":"Pt 4","key":"10.1016\/j.xphs.2021.08.013_bib0053","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer's disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.xphs.2021.08.013_bib0054","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bpj.2014.07.074","article-title":"Beta-amyloid oligomers activate apoptotic BAK pore for cytochrome c release","volume":"107","author":"Kim","year":"2014","journal-title":"Biophys J"},{"key":"10.1016\/j.xphs.2021.08.013_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mad.2014.08.003","article-title":"Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary","volume":"141-142","author":"Bernstein","year":"2014","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.xphs.2021.08.013_bib0056","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","article-title":"ABC efflux transporters in brain vasculature of Alzheimer's subjects","volume":"1358","author":"Wijesuriya","year":"2010","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.xphs.2021.08.013_bib0057","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JAD-2012-112189","article-title":"ABCG2- and ABCG4-mediated efflux of amyloid-beta peptide 1-40 at the mouse blood-brain barrier","volume":"30","author":"Do","year":"2012","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"10.1016\/j.xphs.2021.08.013_bib0058","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1523\/JNEUROSCI.5103-08.2009","article-title":"ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides","volume":"29","author":"Xiong","year":"2009","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.xphs.2021.08.013_bib0059","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.xphs.2021.08.013_bib0060","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2174\/15672050113106660171","article-title":"Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice","volume":"10","author":"Hofrichter","year":"2013","journal-title":"Curr Alzheimer Res"},{"issue":"16","key":"10.1016\/j.xphs.2021.08.013_bib0061","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1073\/pnas.1033060100","article-title":"The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs","volume":"100","author":"Reid","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.xphs.2021.08.013_bib0062","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","article-title":"Glucose transporters in brain in health and disease","volume":"472","author":"Koepsell","year":"2020","journal-title":"Pflugers Arch"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354921004147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:35:22Z","timestamp":1758360922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354921004147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":60,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0022354921004147"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2021.08.013","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Inflammation Induced Changes in Protein Expression of ABC Transporters and Ionotropic Glutamate Receptor Subunit 1 in the Cerebral Cortex of Familial Alzheimer`s Disease Mouse Model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2021.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}